Identification of a novel peptide targeting TIGIT to evaluate immunomodulation of 125I seed brachytherapy in HCC by near-infrared fluorescence
IntroductionHepatocellular carcinoma (HCC) has very poor prognosis due to its immunosuppressive properties. An effective measure to regulate tumor immunity is brachytherapy, which uses 125I seeds planted into tumor. T cell immune receptors with immunoglobulin and ITIM domains (TIGIT) is highly expre...
Main Authors: | Peng Zeng, Duo Shen, Wenbin Shu, Shudan Min, Min Shu, Xijuan Yao, Yong Wang, Rong Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-04-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1143266/full |
Similar Items
-
Clinical efficacy of CT-guided 125I brachytherapy in patients with local residual or recurrent hepatocellular carcinoma after thermal ablation
by: Wenliang Zhu, et al.
Published: (2022-12-01) -
Stereotactic Iodine-125 Brachytherapy for Low-Grade Glioma Treatment: A Monte Carlo study
by: Shahrzad Valizadeh, et al.
Published: (2022-01-01) -
Dose-rate constant and air-kerma strength evaluation of a new 125I brachytherapy source using Monte Carlo
by: Camila de Oliveira Primo
Published: (2021-04-01) -
Impact of Gleason Pattern 5 on outcomes of patients with prostate cancer and iodine-125 prostate brachytherapy
by: Tomoyuki Makino, et al.
Published: (2016-12-01) -
Iodine-125 brachytherapy for choroidal melanoma by using Ocuprosta seeds with indigenous non-collimated plaques: Our initial experience
by: Subina Narang, et al.
Published: (2024-01-01)